Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.
In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.
John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss the evolving collaborative care therapy model in RA.
The randomized, double-blind, controlled trial (N=24,081) included patients with rheumatoid arthritis or osteoarthritis who required chronic NSAID treatment.
The results of 2 randomized controlled trials showed that filgotinib improved quality of life when given in combination with methotrexate or as monotherapy in rheumatoid arthritis.
Fibromyalgia, osteoarthritis, sciatic syndrome, rheumatoid arthritis, and moderate depression may be more prevalent in working-age individuals with vs without migraine.
The available evidence suggests that radiofrequency ablation is a feasible treatment option for chronic hip pain associated with degenerative diseases.
Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases.
Ketoprofen was found to be effective in relieving moderate to severe pain in patients with rheumatoid arthritis.
Although a majority of women with rheumatoid arthritis were previously though to achieve remission during pregnancy, recent studies indicate remission occurs in only 20% to 40% of cases.
In patients with rheumatoid arthritis, vitamin D deficiency was shown to be associated with increased neuropathic pain.
Tocilizumab was associated with significant improvements in hemoglobin and hematocrit over 2 years of treatment in patients with rheumatoid arthritis.
The lack of a standard definition for disease flare made recognizing them complicated, but it's now easier thanks to a new and effective identification tool from OMERACT.
For patients with chronic fatigue syndrome/fibromyalgia or rheumatoid arthritis, morphine has anti-hyperalgesic effects comparable with placebo.
Increased baseline gene expression in peripheral blood may be associated with improved clinical response to methotrexate in rheumatoid arthritis.
Patients with RA have a significantly higher risk of cardiovascular disease, and cardiac magnetic resonance can help with early diagnosis.
Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.
A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.
Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis.
Longitudinal opioid prescribing patterns suggest that regular use among patients with rheumatoid arthritis (RA) is slightly declining.
Peripheral anti-IL-6 cytokine treatment is associated with improvement in depressive symptoms in patients with RA.
Use of the JAK inhibitor peficitinib in combination with certain csDMARDs results in a dose-dependent ACR20 response rate in patients with RA over 12 weeks.
Regeneron and Sanofi announced that the FDA has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis.
MRI may assist in identifying patients with unclassified arthritis who will develop rheumatoid arthritis (RA) — primarily in patients with UA presenting with oligoarthritis.
Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.
No clear association was found between health status and ultrasound remission in patients with rheumatoid arthritis in clinical remission.
High-frequency color Doppler ultrasonography combined with anti-cyclic citrullinated peptide antibody testing may allow for earlier diagnosis of rheumatoid arthritis.
Patients with RA who were treated in the first 6 months had a lower risk of death.
A high prevalence and risk for metabolic syndrome was found in patients with rheumatoid arthritis.
The FDA has approved Renflexis, the second approved biosimilar to Remicade.
Clinical Pain Advisor Articles
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Opioids: Clinician Concern and Prescribing Practices
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Ensuring Safety During Long-Term Opioid Therapy
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain
- Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
- CDC: 8.8% of Individuals in the United States Uninsured in First Half of 2018
- Patient Experiences Shed Light on Diagnostic Errors
- Topical Migraine Trigger Point Treatment as Effective as Injection
- Wikipedia in Medical Education: An Educator's Guide to Crowdsourcing